Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Symbiosis00:58

Symbiosis

Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial.

Nature medicine·2026
Same author

Immunogenicity of HLA-restricted peptide vaccine candidates delivered by self-assembling protein nanoparticle (SAPN) technology.

Vaccine·2025
Same author

IgM, IgG, and IgG Subclass Antibody Responses to Plasmodium falciparum Proteins in Naïve, Malaria-Vaccinated and Semi-Immune Volunteers after Controlled Human Malaria Infection.

The American journal of tropical medicine and hygiene·2025
Same author

Complete attenuation of Plasmodium falciparum sporozoites by atovaquone-proguanil.

EMBO molecular medicine·2025
Same author

Safety, tolerability, and protective efficacy of a radiation-attenuated, whole sporozoite malaria vaccine in children in Gabon: a randomised, double-blind, placebo-controlled, phase 2 trial.

The Lancet. Infectious diseases·2025
Same author

Assessment of Health Status and Creation of a Registry of Potential Research Participants Aged 1.5 to 50 Years on Bioko Island, Equatorial Guinea.

The American journal of tropical medicine and hygiene·2025

Related Experiment Video

Updated: Jun 17, 2026

Generating Genetically Modified Plasmodium berghei Sporozoites
10:16

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

Molecular vaccines for malaria.

Joseph T Bruder1, Evelina Angov, Keith J Limbach

  • 1GenVec, Inc., Gaithersburg, MD, USA. jbruder@genvec.com

Human Vaccines
|January 12, 2010
PubMed
Summary

Developing effective vaccines, especially for challenging diseases like malaria, requires advanced strategies beyond traditional methods. This review explores molecular antigen design, adjuvant improvements, and delivery systems for novel vaccine development.

Area of Science:

  • Vaccinology
  • Immunology
  • Molecular Biology

Background:

  • Traditional vaccine development relies on attenuated or inactivated organisms, often without fully understanding protective antigens or mechanisms.
  • This approach has proven insufficient for diseases like malaria, necessitating new strategies.
  • Rational molecular design principles are now being applied to create novel vaccines for challenging pathogens.

Purpose of the Study:

  • To review the molecular aspects of developing novel vaccines for malaria.
  • To discuss advancements in antigen design, adjuvants, and delivery systems for vaccine development.

Main Methods:

  • Review of current research in rational vaccine design.
  • Analysis of molecular strategies for antigen identification and optimization.

More Related Videos

Phenotypic Analysis of Rodent Malaria Parasite Asexual and Sexual Blood Stages and Mosquito Stages
08:23

Phenotypic Analysis of Rodent Malaria Parasite Asexual and Sexual Blood Stages and Mosquito Stages

Published on: May 30, 2019

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

Related Experiment Videos

Last Updated: Jun 17, 2026

Generating Genetically Modified Plasmodium berghei Sporozoites
10:16

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

Phenotypic Analysis of Rodent Malaria Parasite Asexual and Sexual Blood Stages and Mosquito Stages
08:23

Phenotypic Analysis of Rodent Malaria Parasite Asexual and Sexual Blood Stages and Mosquito Stages

Published on: May 30, 2019

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

  • Evaluation of adjuvant technologies and vaccine delivery systems.
  • Main Results:

    • Significant progress is being made in applying rational design to vaccine development.
    • Understanding molecular mechanisms is crucial for overcoming challenges in vaccine efficacy.
    • Integration of antigen design, adjuvants, and delivery systems is key.

    Conclusions:

    • Novel vaccine development for diseases like malaria requires a focus on molecular design principles.
    • Advancements in antigen design, adjuvants, and delivery systems are critical for creating effective vaccines.
    • This integrated approach holds promise for tackling refractory pathogens.